A new type of treatment for osteoarthritis, currently in canine clinical trials, shows promise for eventual use in humans.
The treatment, developed by Cornell biomedical engineers, is a synthetic version of a naturally occurring joint lubricant that binds to the surface of cartilage in joints and acts as a cushion during high-impact activities, such as running.
“When the production of that specific lubricant goes down, it creates higher contact between the surfaces of the joint and, over time, it leads to osteoarthritis,” said David Putnam, a professor in the College of Engineering with appointments in the Meinig School of Biomedical Engineering and the Smith School of Chemical and Biomolecular Engineering.
Putnam is senior author of “Boundary Mode Lubrication of Articular Cartilage With a Biomimetic Diblock Copolymer,” published June 4 in Proceedings of the National Academy of Sciences, USA. Zhexun Sun, a postdoctoral researcher in Putnam’s lab, is the paper’s first author.
The study focuses on a naturally occurring joint lubricant called lubricin, the production of which declines following traumatic injuries to a joint, such as a ligament tear in a knee.
The knee is lubricated in two ways – hydrodynamic mode and boundary mode.
Hydrodynamic mode lubrication occurs when the joint is moving fast and there isn’t a strong force pushing down on it. In this mode, joints are lubricated by compounds like hyaluronic acid (HA) that are thick and gooey, like car oil. There are numerous HA products on the market, approved by the Food and Drug Administration, for treating hydrodynamic mode lubrication disorders.
But HA is ineffective when strong forces are pushing down on the joint, such as those that occur during running or jumping. In these instances, thick gooey HA squirts out from between the cartilage surfaces, and boundary mode lubrication is necessary. Under these forces, lubricin binds to the surface of the cartilage. It contains sugars that hold on to water, to cushion hard forces on the knee.
In the paper, the researchers describe a synthetic polymer they developed that mimics the function of lubricin and is much easier to produce. “We are in clinical trials, with dogs that have osteoarthritis, with our collaborators at Cornell’s College of Veterinary Medicine,” Putnam said.
Those collaborators – Ursula Krotscheck and Kei Hayashi, both associate professors in the Section of Small Animal Surgery in the Department of Clinical Sciences – use a force plate to measure the efficacy of the treatments. The force plate quantifies the amount of force that a dog exerts with each paw, to measure whether they are favoring one paw over another.
“Once we finalize the efficacy study in dogs, we will be in a very good position to market the material for veterinary osteoarthritis treatment,” Putnam said. From there, the human market for a lubricin substitute should follow, just as HA has been made available for human use, mainly in knees.
The Latest on: Osteoarthritis
via Google News
The Latest on: Osteoarthritis
- IISc. makes headway in osteoarthritis treatmenton July 6, 2020 at 6:58 pm
To treat osteoarthritis, a chronic joint condition, researchers at the Indian Institute of Science (IISc), have developed a micro-particle formulation that allows sustained release of drugs.
- A step closer towards a more effective treatment for osteoarthritison July 6, 2020 at 6:30 am
Researchers at the Indian Institute of Science (IISc) have developed a microparticle formulation that allows sustained release of drugs to treat osteoarthritis, a chronic joint condition.
- IISc Researchers Develop Microparticle Formulation For Osteoarthritis Treatmenton July 6, 2020 at 5:52 am
Researchers at the Indian Institute of Science (IISc) have developed a microparticle formulation that allows sustained release of drugs to treat osteoarthritis, a chronic joint condition. They have, ...
- Osteoarthritis of the Neck & Back Workshop via Webex at Virtualon July 3, 2020 at 9:25 am
Learn to better understand your diagnosis, learn about good posture habits and tips for easing daily activities, and links to community resources. Although we endeavour to provide the most accurate ...
- Spa therapy with physical rehabilitation is an alternative to usual spa therapy protocol in symptomatic knee osteoarthritison July 3, 2020 at 2:09 am
The objective of the study was to demonstrate the non-inferiority of low-frequency spa therapy combined with rehabilitation (Spa-rehab) versus standard spa therapy at 6 months for symptomatic knee ...
- Synovial cell cross-talk with cartilage plays a major role in the pathogenesis of osteoarthritison July 2, 2020 at 2:03 am
We elucidated the molecular cross-talk between cartilage and synovium in osteoarthritis, the most widespread arthritis in the world, using the powerful tool of single-cell RNA-seq ...
- CBD For Dogs? New Research Backs Canine Cannabis Use For Osteoarthritison July 1, 2020 at 12:34 pm
Is your dog suffering from canine osteoarthritis? A new study suggests that CBD may help dogs with this painful arthritic condition. Canine osteoarthritis is an inflammatory condition marked by pain, ...
- Preliminary CBD Treatments Prove Effective For Osteoarthritis in Dogson June 30, 2020 at 9:22 am
Pets are often considered to be a part of peoples' families, but they unfortunately also suffer from many of the same ailments as their human owners. One ...
- Osteoarthritis pain is caused by more than just bad luckon June 18, 2020 at 10:25 pm
Osteoarthritis (OA) is the form of arthritis that can be likened to wearing the tread on your tires down after years of driving. It is quite common in the general population and people who ...
- Osteoarthritis Treatment Market 2020 Opportunity, Challenge, Drivers, Restraint, Trend, Demand And Global Business Growth By 2027 | DBMR Updateson June 17, 2020 at 11:07 am
Jun 17, 2020 (CDN Newswire via Comtex) -- The Osteoarthritis Treatment Market analysis report focuses on global leading industry players providing information such as company profiles, product ...
via Bing News